Skip to main content
. 2022 Oct 10;2022:2151840. doi: 10.1155/2022/2151840

Table 1.

Comparisons of the baseline characteristics between the alive group and the dead group.

Variables Total (n = 2085) Alive (n = 1390) Dead (n = 695) Statistics P
CHF, n (%) χ 2 = 5.062 0.024
 No 1508 (72.33) 1027 (73.88) 481 (69.21)
 Yes 577 (27.67) 363 (26.12) 214 (30.79)
AF, n (%) χ 2 = 0.164 0.686
 No 1154 (55.35) 765 (55.04) 389 (55.97)
 Yes 931 (44.65) 625 (44.96) 306 (44.03)
Diabetes mellitus, n (%) χ 2 = 0.192 0.662
 No 1451 (69.59) 963 (69.28) 488 (70.22)
 Yes 634 (30.41) 427 (30.72) 207 (29.78)
Respiratory failure, n (%) χ 2 = 99.754 <.001
 No 1280 (61.39) 958 (68.92) 322 (46.33)
 Yes 805 (38.61) 432 (31.08) 373 (53.67)
Renal failure, n (%) χ 2 = 13.627 <.001
 No 1623 (77.84) 1115 (80.22) 508 (73.09)
 Yes 462 (22.16) 275 (19.78) 187 (26.91)
Malignant cancer, n (%) χ 2 = 15.376 <.001
 No 1792 (85.95) 1224 (88.06) 568 (81.73)
 Yes 293 (14.05) 166 (11.94) 127 (18.27)
Thrombolytic, n (%) χ 2 = 3.202 0.074
 No 1777 (85.23) 1171 (84.24) 606 (87.19)
 Yes 308 (14.77) 219 (15.76) 89 (12.81)
Anticoagulation, n (%) χ 2 = 11.088 <.001
 No 235 (11.27) 134 (9.64) 101 (14.53)
 Yes 1850 (88.73) 1256 (90.36) 594 (85.47)
Hypertension, n (%) χ 2 = 3.542 0.060
 No 793 (38.03) 509 (36.62) 284 (40.86)
 Yes 1292 (61.97) 881 (63.38) 411 (59.14)
Liver disease, n (%) χ 2 = 23.429 <.001
 No 1942 (93.14) 1321 (95.04) 621 (89.35)
 Yes 143 (6.86) 69 (4.96) 74 (10.65)
Heart rate (time/min), mean ± SD 85.36 ± 20.10 83.56 ± 18.71 88.95 ± 22.21 t = −5.50 <.001
SBP (mmhg), M(Q1,Q3) 137 (116, 155) 138 (118,155) 134 (113,155) Z = −2.151 0.031
DBP (mmhg), M (Q1, Q3) 70 (58, 83) 70 (58, 83) 70 (58, 82) Z = −0.187 0.851
MAP (mmhg), M (Q1, Q3) 89 (76, 102) 89 (77, 103) 88 (75, 102) Z = −1.072 0.284
Respiratory rate (time/min), M (Q1, Q3) 18.00 (15.00, 22.00) 18.00 (15.00, 21.00) 19.00 (15.00, 24.00) Z = 4.577 <.001
Temperature (°C), mean ± SD 36.48 ± 2.72 36.59 ± 1.80 36.26 ± 3.96 t = 2.15 0.032
SOFA, M (Q1, Q3) 2.00 (1.00, 5.00) 2.00 (0.00, 4.00) 4.00 (1.00, 6.00) Z = 7.945 <.001
SAPSII, M (Q1, Q3) 38.00 (30.00, 47.00) 35.00 (28.00, 44.00) 43.00 (35.00, 53.00) Z = 12.891 <.001
OASIS, mean ± SD 33.08 ± 9.92 31.53 ± 9.68 36.17 ± 9.67 t = −10.33 <.001
WBC (K/μl), M(Q1, Q3) 10.30 (7.80, 13.80) 9.90 (7.70, 13.30) 11.50 (8.00, 15.80) Z = 5.198 <.001
PLT (K/μl), M (Q1, Q3) 215.00 (160.00, 279.00) 217.00 (164.00, 276.00) 211.00 (153.00, 285.00) Z = −1.257 0.209
Hemoglobin (g/dl), mean ± SD 11.87 ± 2.31 12.03 ± 2.29 11.55 ± 2.32 t = 4.55 <.001
RDW percent, mean ± SD 14.59 ± 1.99 14.37 ± 1.88 15.01 ± 2.11 t = −6.79 <.001
Hematocrit percent, mean ± SD 35.68 ± 6.51 36.05 ± 6.48 34.93 ± 6.53 t = 3.70 <.001
Creatinine (mg/dl), M (Q1,Q3) 1.00 (0.80, 1.40) 1.00 (0.80, 1.30) 1.10 (0.80, 1.60) Z = 4.686 <.001
INR, M (Q1,Q3) 1.20 (1.10, 1.40) 1.20 (1.10, 1.30) 1.20 (1.10, 1.40) Z = 6.144 <.001
BUN (mg/dl), M (Q1,Q3) 20.00 (14.00, 29.00) 19.00 (14.00, 27.00) 22.00 (16.00, 34.00) Z = 6.401 <.001rep
Glucose (mg/dl), M (Q1,Q3) 130.00 (107.00, 167.00) 126.00 (106.00, 160.00) 136.00 (110.00, 184.00) Z = 4.853 <.001
Bicarbonate (mEq/l), mean ± SD 23.61 ± 4.26 23.91 ± 3.97 23.00 ± 4.72 t = 4.36 <.001
Sodium (mEq/l), mean ± SD 139.24 ± 4.64 139.37 ± 4.42 138.98 ± 5.03 t = 1.77 0.076
Potassium (mEq/l), mean ± SD 4.18 ± 0.77 4.15 ± 0.73 4.24 ± 0.83 t = −2.49 0.013
Charlson comorbidity index, M (Q1,Q3) 5.00 (3.00, 8.00) 5.00 (3.00, 7.00) 6.00 (3.00, 8.00) Z = 2.891 0.004
BUN/Cr, M (Q1, Q3) 19.38 (15.00, 24.44) 19.00 (15.00, 23.75) 20.00 (15.00, 25.71) Z = 2.756 0.006

CHF: congestive heart failure; AF: atrial fibrillation; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; WBC: white blood cell; PLT: platelets; RDW: red cell distribution width; INR: International Normalized Ratio; SOFA: the Sequential Organ Failure Assessment; SAPSII: the Simplified Acute Physiology Score II; OASIS: the Oxford Acute Severity of Illness Score; BUN: blood urea nitrogen; Cr: creatinine.